Home > Healthcare > Medical Services > Clinical Trial Equipment & Ancillary Solutions Market

Clinical Trial Equipment & Ancillary Solutions Market Trends

Report ID: GMI9268
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Clinical Trial Equipment & Ancillary Solutions Market Trends

The growing focus on patient-centric trials, prioritizing patient experience and convenience via remote monitoring, decentralized trials, and virtual visits, is further driving the need for clinical trial equipment and ancillary solutions. This trend has shifted the focus toward advanced technologies and tools for clinical data management systems and analysis, thereby fostering market to meet the evolving needs of patient-centric research methods.

For instance, in April 2021, CEVA Logistics introduced 'CEVA FORPATIENTS,' a new sub-brand focused on enhancing patient outcomes with comprehensive healthcare logistics solutions. It prioritizes patient-centricity by managing last-mile services for healthcare and pharmaceutical companies, meeting quality standards and study requirements. This initiative aims to broaden ancillary services supporting patient-centered studies.

Therefore, increasing research funding, and advancements in ancillary services along with growing adoption of clinical trial supply and logistics solutions foster the market demand for comprehensive solutions in the healthcare sector.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical trial equipment & ancillary solutions industry size recorded USD 1.5 billion in 2023 and will expand at a 7.5% CAGR between 2024 and 2032, driven by the rising complexity of clinical trials, the globalization of clinical research, and advancements in technology.

The diagnostic equipment segment in the market will reach USD 1.1 billion by 2032, owing to increasing emphasis on precision medicine and personalized healthcare.

North America clinical trial equipment & ancillary solutions industry size was USD 730.7 million in 2023, primarily due to its advanced healthcare infrastructure, robust research and development activities, and supportive regulatory framework.

Key players operating in the clinical trial equipment & ancillary solutions industry are Ancillare, LP., Axelerist Financial, Biocair, ICON plc, Imperial CRS, LLC, Marken, MESM UK., Myonex, Nuvisan, Oximio, Parexel International (MA) Corporation, Quipment SAS, and Thermo Fisher Scientific Inc.